Rinoserebral Mukormikozlu Olgunun Yönetimi

Authors

Helin Şahintürk
https://orcid.org/0000-0003-0159-4771

Synopsis

A 48-year-old female patient with a 20-year history of Type 2 Diabetes Mellitus developed diabetic ketoacidosis (DKA) and suffered cardiac arrest following rhinoplasty surgery, after which she was admitted to the intensive care unit following successful resuscitation. Initial management included broad-spectrum antibiotics, fluid resuscitation, insulin infusion, continuous renal replacement therapy, and inotropic support for DKA and septic shock. On the 11th day of admission, necrotic lesions suggestive of mucormycosis were identified in the nasal mucosa, pathologically confirmed, and treated with intravenous liposomal amphotericin B along with surgical debridement. Despite aggressive surgical intervention, intensive antifungal, and antibacterial therapies, the patient developed multidrug-resistant Acinetobacter baumannii infection and succumbed to septic shock on the 41st day of hospitalization. This case highlights that rhinocerebral mucormycosis is a life-threatening fungal infection particularly affecting patients with DKA and uncontrolled diabetes, carrying high mortality despite timely diagnosis, extensive debridement, and targeted antifungal management.

References

Kauffman CA, Malani AN. Zygomycosis: an emerging fungal infection with new options for management. Curr Infect Dis Rep 2007; 9:435-40.

Farmakiotis D, Kontoyoyiannis DP. Mucormycoses. Infect Dis Clin North Am 2016: 30:143-63.

Lanternier F, Sun HY, Ribaoud P, et al. Mucormycosis in organ and stem cell transplant recipients. Clin Infect Dis 2012: 54:1629.

Almyroudis NG, Sutton DA, Linden P, et al. Zygomycosis in solid organ transplant recipients in a tertiary transplant center and review of the literatüre. Am J Transplant 2006; 6:2365-74.

Lelievre L, Garcia-Hermoso D, Abdoul H, et al. Posttraumatic mucormycosis: a nationwidw study in France and review of the literatüre. Medicine (Baltimore) 2014: 93:395-404.

Legrand M, Gits-Muselli M, Boutin L, et al. Detection of Circulating Mucorales DNA in Critically Ill Burn Patients: Preliminary Report of a Screening Strategy for Early Diognosis and Treatment. Clin Infect Dis 2016:63:1312-17.

Prakash H, Chakrabarti A. Global Epidemiology of Mucormycosis. J Fungi (Basel). 2019 Mar 21;5(1):26. doi: 10.3390/jof5010026.

Rammaert B, Lanternier F, Zahar JR, et al. Healthcare-associated mucormycosis. Clin. Infect. Dis. 2012, 54 (Suppl. 1), S44–S54.

Rajagopalan S. Serious infections in elderly patients with diabetes mellitus. Clin Infect Dis 2005;40:990-6.

Shields JA, Shields CL. Eyelid, Conjunctival, and Orbital Tumors: An Atlas and Textbook, 3rd ed, L,ppincott Williams&Wilkins, Pheladelphia 2016.

Machourt M, Larche J, Burton K, et al. Genetic identification of the main oportunistic Mucorales by PCR-restriction fragment length polymorphism. J Clin Microbiol 2006; 44:805-10.

Hammond SP, Bialek R, Milner Da, et al. Molecular methods to improve diagnosis and identification of mucormycosis. J Clin Microbiol 2011; 49:2151-3.

Walsh TJ, Gamaletsou MN, McGinnis MR, et al. Early clincal and laboratory diagnosis of invasive pulmonary, extrapulmonary, and disseminated mucormycosis (zygomycosis). Clin Infect Dis 2012; 54 Suppl 1:S55-60.

Schrödl W, Heydel T, Schwartze VU, et al. Direct analysis and identification of pathogenic Lichtheimia species by matrix-asisted laser desorption ionization-time of flight analyzer- mediated mass spectrometry. J Clin Microbiol 2012; 50:419-27.

Cassagne C, Ranque S, Normand AC, et al. Mould routine identification in the clinical laboratory by matrix-asisted laser desorption ionization-time of -flight mass spectrometry. PLoS One 2011; 6:e28425. doi: 10.1371/journal.pone.0028425.

Ling H, Yuan Z, Shen J, et al. Accuracy of matrix-asisted laser desorption ionization-time of flight mass spectrometry for identification of clinical pathogenic fungi: a meta-analysis. J Clin Microbiol 2014; 52:2573-82.

Spellberg B, Walsh TJ, Kontoyiannis DP, et al. Recent advances in the management of mucormycosis: from bench to bedside. Clin Infect Dis 2009; 48:1743-51.

Farmakiotis D, Kontoyiannis DP. Mucormycoses. Infect Dis Clin North Am 2016; 30:143-63.

Zilberberg MD, Shorr AF, Huang H, et al. Hospital days, hospitalization costs, and inpatient mortality among patients with mucormycosis: a retrospective analysis of US hospital discharge data. BMC Infect Dis. 2014 Jun 5;14:310. doi: 10.1186/1471-2334-14-310.

Roden MM, Zaoutis TE, Buchanan WL, et al. Epidemiology and outcome of zygomycosis: a review of 929 reported cases. Clin Infect Dis. 2005 Sep 1;41(5):634-53.

Karslıoğlu French E, Donihi AC, et al. Diabetic ketoacidosis and hyperosmolar hyperglicemic syndrome: review of acute decompensated diabetes in adult patients. BMJ 2019;365:l1114. doi: 10.1136/bmj.l1114.

Lebovitz HE, Banerji MA. Ketosis-Prone Diabetes (Flatbush Diabetes): an Emerging Worldwide Clinically Important Entity. Curr Diab Rep. 2018;18(11):120. doi:10.1007/s11892-018-1075-4

Gagakhedkar GR. Diabetic Ketoacidosis and Intensive Care. Journal of Research & Innovation in Anesthesia 2019; 4(2):29-31.

Brutsaert E, (2019). Diabetic Ketoacidosis (DKA)- Endocrine and Metabolic Disorders – MSD Manual Professional Edition. Retrieved 20 November 2019, from https:/www.msdmanuals.com/en-in/Professional/endocrine-and-metabolic-disorders/diabetes-mellitus-and-disorders-of-carbonhydrate-metabolism/diabetic-ketoacidosis-dka.

Kitabchi AE, Umpierrez GE, Miles JM, et al. Hyperglisemic crises in adult patients with diabetes: a consensus statement from the American Diabetes Association. Diabetes Care 2009;32(7):1335-1343.

Ramanesh A. Incidence and long term outcomes of adult patients with diabetic ketoacidosis admitted to intensive care: a retrospective cohort study. J Intensive Care Soc 2016;17(3):222-233.

Published

January 13, 2022

License

License